About
metaLead develops selective, stable, and orally available molecular treatments for metal-related diseases, including toxic metal poisoning and rare disorders like Wilson disease, aiming to improve efficacy and reduce side effects compared to current standards of care.
Explore metaLead's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.